Your wound isn't healing because your body needs help.
Creams, bandages, and compression treat the surface. They don't address the underlying biology — inadequate circulation, stalled collagen production, and a wound bed that can't sustain repair.
Electroceutical therapy (tPEMF) works differently. Each 15-minute session triggers a biological cascade — nitric oxide release, new blood vessel formation, accelerated collagen synthesis — that compounds over a 4–8 week treatment course. This is not a one-time fix. It is accretive healing.
Who benefits from wound electroceutical therapy
These patients already spend significant out-of-pocket dollars on wound care supplies — often on products that treat the symptom without addressing the biology.
Stage III / IV Pressure Ulcers
The deepest, most difficult pressure injuries — often in patients with limited mobility. Standard wound care can take months. The biological cascade triggered by tPEMF has been shown to reduce sacral ulcer area by 72% in paraplegic patients.
72% reduction in sacral ulcer area
Source: Kloth, 1999
Diabetic Foot Ulcers
Chronic lower-extremity wounds in people with diabetes are among the costliest and most dangerous non-healing wounds. Poor circulation limits the body's ability to form new blood vessels — the exact mechanism tPEMF addresses.
500% increase in neovascularization
Source: Roland 2000, Weber 2004
Venous Stasis Wounds
Leg ulcers caused by chronic venous insufficiency are notoriously slow to close. The inflammation is persistent, circulation is compromised, and conventional compression alone is often insufficient.
800% faster healing vs. standard care
Source: Kloth, 1999
Non-Healing Surgical Wounds
Post-operative wounds that fail to progress — often in patients with compromised immune function, infection history, or poor nutritional status. tPEMF accelerates collagen synthesis and strengthens wound tensile integrity.
59% faster surgical wound closure
Source: Strauch & Pilla, 2007
Four-session cascade — healing that compounds
Each treatment session builds on the prior one. The biological changes triggered by early sessions create the conditions for more advanced repair in later sessions. This is the accretive treatment model.
Nitric Oxide Release
The targeted electromagnetic field stimulates nitric oxide synthase activity in endothelial cells. Nitric oxide is the body's own vasodilator — it opens capillary beds and signals the wound environment to begin repair.
Neovascularization
Elevated nitric oxide triggers angiogenesis — the formation of new capillaries directly into the wound bed. Studies show a 500% increase in new vessel formation compared to control tissue. Blood supply is the prerequisite for everything that follows.
Collagen Synthesis
With restored circulation, fibroblasts receive the oxygen and nutrients needed to produce collagen — the structural protein that rebuilds the wound matrix. Wound tensile strength increases by 44% compared to untreated tissue.
Wound Closure
As the new tissue matrix matures, the wound edges migrate inward. The accelerated healing process — driven by genuine biological repair, not surface dressings — produces durable closure that holds.
Why this matters for patients who have "tried everything"
Most wound care products address the wound surface — they protect, debride, or dress. Electroceutical therapy addresses the biology underneath: the vascular supply, the cellular signaling, the collagen machinery. These are the systems that actually determine whether a wound closes.
Peer-reviewed outcomes across wound types
The data below come from published peer-reviewed studies of pulsed electromagnetic field therapy in human wound healing.
Faster pressure ulcer healing rate
Source: Kloth, 1999
Increase in neovascularization
Source: Roland 2000, Weber 2004
Reduction in sacral ulcer area — paraplegic patients
Source: Kloth, 1999
Faster surgical wound healing rate
Source: Strauch & Pilla, 2007
Acceleration in tendon healing
Source: Strauch & Pilla, 2006
Increase in wound tensile strength
Source: Strauch, 2007
Studies cited include Kloth (1999), Roland (2000), Weber (2004), Strauch & Pilla (2006, 2007), and Strauch (2007). All are published in peer-reviewed journals. This educational summary does not constitute a therapeutic claim. Consult your wound care physician for individual treatment decisions.
Insurance coverage exists. Most patients don't know.
CMS established a national coverage determination for PEMF in chronic wound management. Medicare patients may be eligible for reimbursed sessions.
Medicare Patients
CMS National Coverage Determination NCD 270.1 covers electrical stimulation and electromagnetic therapy for wound management. PEMF sessions are billed under HCPCS code G0329, with Medicare reimbursement of approximately $215 per session.
HSA / FSA Eligible
Physician-prescribed electroceutical wound therapy qualifies as an IRS Section 213(d) medical expense. You can pay for your treatment course — device and sessions — using pre-tax HSA or FSA dollars. A letter of medical necessity from your wound care physician is typically required.
How to Get a Prescription
Bring this page to your next wound care appointment. Ask your physician whether electroceutical tPEMF therapy is appropriate for your wound type, whether they can bill G0329, and whether you qualify for a letter of medical necessity for HSA/FSA use.
Real Cost of Standard Wound Care
What daily dressings cost over months — vs. one completed tPEMF course
Most chronic wound patients spend more on dressings and clinic copays in six months than a Medicare-covered tPEMF course costs. The wound is also still open. tPEMF resolves wounds in 8 weeks on average, with Medicare covering G0329 sessions directly.
How long has the wound been open?
Used to estimate accumulated cost of current wound care
Wound severity (daily dressing cost)
Pick the closest match — costs are US wound supply averages
Your insurance for tPEMF
Medicare covers G0329 — patient pays 20% coinsurance
Current approach — 6 months
Supplies $4,500 + clinic copays $1,032
Completed tPEMF course (16 sessions over 8 weeks)
G0329 billed by your clinician · ~8-week protocol · wound closes
You spend this much more on dressings + visits
Over 6 months vs. one tPEMF course — and the wound is still open
Time-to-closure framing: Standard wound care averages 6–12 months for chronic wounds. tPEMF protocols complete in 8 weeks. The cost comparison above doesn't include the value of an actually-closed wound, no recurrent infections, no amputation risk, and time back from daily dressing changes.
Cost estimates: dressing supplies $10/day (mild) to $40/day (severe) based on US retail averages; wound center visits ~4×/month at the copay shown. tPEMF cost reflects 16 sessions × ~$215 (G0329) under the selected insurance. Medicare coinsurance is 20% of allowable charge; commercial varies by plan. Cash-pay column shows HSA/FSA-eligible amount with no insurance contribution. Consult your wound care physician and your MAC for coverage specifics.
For Wound Care Clinicians
Prescribe tPEMF. Bill G0329. Get paid per session.
CMS established HCPCS code G0329 for electromagnetic wound therapy in 2004 under National Coverage Determination 270.1. The billing right goes to the treating clinician — not the device company. Most wound care physicians have never billed it.
HCPCS G0329
Electromagnetic Therapy for Wounds
~$215 / session
Per-session Medicare reimbursement under NCD 270.1. Billed by the treating clinician or facility under their own NPI. Established national coverage since 2004.
Add to same visit
99201–99215
E&M billed separately for wound assessment at the same encounter
Wound measurement
97597 / 97598
Debridement codes may apply separately — check with your MAC
Revenue Per Patient — Standard 8-Week Course
$3,440
16 sessions × ~$215. On top of wound assessment E&M. Documentation generated by the platform at each session.
2× per week
session frequency
8 weeks
protocol length
~$215
G0329 rate
$3,440
per patient
Annual Revenue by Patient Volume
Based on 16-session course at $215/session. E&M codes not included.
Who Can Bill G0329
Three-Phase Protocol — How the Billing Compounds
3×/week
12 sessions
Nitric oxide cascade + neovascularization
2×/week
8 sessions
Collagen synthesis + wound contraction
1–2×/week
8–16 sessions
Maintenance — wound closure and tensile strengthening
Documentation Requirements
Five elements CMS requires for G0329
The Billing Gap
Same visit. Additional revenue.
tPEMF adds a billable event to a visit that was already happening. The dressing change continues. The G0329 session adds 15 minutes and ~$215.
Source: CMS HCPCS G0329, National Coverage Determination 270.1 (established 2004). Medicare reimbursement of ~$215 is approximate; rates vary by MAC and geographic region. Annual rate updates apply. This is educational content, not billing advice — consult your compliance team and MAC for coverage determinations specific to your patient population.
Talk to your wound care physician about tPEMF
Bring the clinical data on this page to your next wound care appointment. Ask whether electroceutical therapy is appropriate for your wound type.
Medicare patients: ask about billing code G0329. All patients: ask for a letter of medical necessity to unlock HSA/FSA eligibility.
This page is educational content about published research on pulsed electromagnetic field (PEMF) therapy. It is not a therapeutic claim or medical advice. Coverage determinations depend on individual patient circumstances, payer policies, and physician judgment. CMS reimbursement rates are approximate and subject to geographic and annual adjustments. Consult your physician and payer before initiating treatment.
Powered by SofPulse tPEMF technology. SofPulse is CE Marked for wound care and edema. CMS NCD 270.1 / G0329 references are drawn from publicly available CMS coverage determination databases.